tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yaron Werber, 151 are a BUY (75.88%), 47 are a HOLD (23.62%), 1 are a SELL (0.5%).
Analyst Yaron Werber, currently employed at TD COWEN, carries an average stock price target met ratio of 64.11% that have a potential upside of 23.24% achieved within 335 days.
Yaron Werber’s has documented 391 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on AMGN, Amgen.
Analyst best performing recommendations are on GMAB (GENMAB AS).
The best stock recommendation documented was for GMAB (GENMAB AS) at 10/26/2026. The price target of $52 was fulfilled within 2 days with a profit of $7.31 (16.36%) receiving and performance score of 81.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Aug-2019
$425
$-36.26 (-7.86%)
$270
Buy Since 28-Apr-2023
$536
$74.74 (16.20%)
$370
Hold Since 10-Jan-2025
$460
$-1.26 (-0.27%)
$430
Hold Since 24-Nov-2025
$398
$-63.26 (-13.71%)
$380
Hold Since 10-Feb-2022
$410
$-51.26 (-11.11%)
$359
Which stock is Yaron Werber most bullish on?
Which stock is Yaron Werber most reserved on?
What Year was the first public recommendation made by Yaron Werber?
